Pain Neuroscience Education and Physical Exercise Program in Chronic Back Pain

NCT03654235 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 170

Last updated 2020-02-21

No results posted yet for this study

Summary

This study evaluates the effects of a pain neuroscience education (PNE) and physical exercise (PE) program in patients with chronic back pain. Half of participants receive PNE and PE program supervised by a physiotherapist and the other half receive usual physiotherapy care supported by physiotherapy protocols in primary care.

Conditions

Interventions

OTHER

Health Education

6 pain neuroscience education sessions (10 hours) and delivery of printed reinforcement material.

OTHER

Physical exercise

Group physical exercise program (18 sessions; 3 sessions/week) leaded by a physiotherapist. It includes exercises to improve strength, coordination, balance and aerobic capacity. Work with double tasks, recreational activities to overcome kinesiophobia and activities to do at home are used in the program.

OTHER

Usual care in Primary Care Physiotherapy Units

Treatment supported by the protocol of primary care of physiotherapy in the health service of Castilla y León that was in force at the time of the intervention. Patients receive 15 sessions of analgesic electrotherapy, thermotherapy and standardized physical exercise

Sponsors & Collaborators

  • Castilla-León Health Service

    collaborator OTHER
  • University of Valladolid

    collaborator OTHER
  • Fundacion para la Investigacion y Formacion en Ciencias de la Salud

    lead OTHER

Principal Investigators

  • Miguel A. Galán Martín · Castilla-León Health Service

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-02-01
Primary Completion
2020-11-30
Completion
2020-12-30

Countries

  • Spain

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03654235 on ClinicalTrials.gov